stockrowCigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
- Revenue
- +5.64%
- EPS
- −21.6%
- Free cash flow
- −18.1%
- Total debt
- −8.51%
Quarter to September 2026, against a year earlier
Follow CI
Alert me
Cigna Group (CI) Operating cash flow
Cigna Group's operating cash flow for fiscal 2025 was $9.6B, down 7.35% from $10.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $9.4B. Over the past ten years it has ranged from $2.9B (fiscal 2015) to $11.8B (fiscal 2023); the current reading is higher than 73% of that period. Cigna Group ranks 3rd of 12 Healthcare Plans companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $9.6B | (7.35%) |
| FY2024 | $10.4B | (12.27%) |
| FY2023 | $11.8B | 36.47% |
| FY2022 | $8.7B | 20.37% |
| FY2021 | $7.2B | (30.52%) |
| FY2020 | $10.4B | 9.12% |
| FY2019 | $9.5B | 151.59% |
| FY2018 | $3.8B | (7.73%) |
| FY2017 | $4.1B | 1.49% |
| FY2016 | $4.0B | 37.27% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $2.6B | — |
| Jun 2026 | −$421.0M | — |
| Mar 2026 | $1.1B | (81.61%) |
| Dec 2025 | $6.1B | 79.90% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $26.2B |
| CVS CVS Health Corporation compare | $18.7B |
| CI Cigna Group | $9.4B |
| ELV Elevance Health, Inc. compare | $7.6B |
| CNC Centene Corporation compare | $4.7B |
| OSCR Oscar Health, Inc. compare | $4.2B |
| HUM Humana Inc. compare | $3.7B |
| MOH Molina Healthcare, Inc compare | $331.0M |
| PGNY Progyny, Inc. compare | $207.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on CI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement